Olivier Gires1,2, Frank Haubner3, Alexandra Blancke Soares1, Robert Meier4, Gregor Liebsch4, Sabina Schwenk-Zieger1, Martin E Kirmaier5,6, Sebastian Theurich5,6, Magdalena Widmann1, Martin Canis1. 1. Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. 2. Clinical Cooperation Group "Personalized Radiotherapy in Head and Neck Cancer", Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, 85764, Neuherberg, Germany. 3. Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Frank.Haubner@med.uni-muenchen.de. 4. PreSens Precision Sensing GmbH, Am Biopark 11, 93053, Regensburg, Germany. 5. Department of Medicine III, LMU University Hospital, Ludwig Maximilians University Munich, 81377, Munich, Germany. 6. Cancer and Immunometabolism Research Group, Gene Center LMU, Ludwig Maximilians University Munich, 81377, Munich, Germany.
Abstract
BACKGROUND: pO2 and pH are physiological parameters relevant for different processes in health and disease, including wound healing and cancer progression. Head and neck squamous cell carcinomas (HNSCC) and oesophageal squamous cell carcinomas (ESCC) have a high rate of local recurrence that is partly related to treatment-resistant residual tumour cells. Hence, novel diagnostic tools are required to visualise potential residual tumour cells and thereby improve treatment outcome for HNSCC and ESCC patients. We developed a device to spatiotemporally measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) to distinguish HNSCC and ESCC cells from healthy cells in vitro, exploiting general metabolic differences between cancer cells and healthy cells. METHODS: OCR and ECAR were measured via a newly developed device named STO2p-Q (SpatioTemporal O2 and pH Quantification) using the VisiSens technology based on ratiometric fluorescence imaging, facilitating spatiotemporal resolution. Results were confirmed using extracellular flux analyses (Seahorse technology). RESULTS: STO2p-Q is described and used to measure OCR and ECAR in HNSCC and ESCC cell lines and normal fibroblast and epithelial cells as components of the tumour microenvironment. OCR measurements showed differences amongst HNSCC and ESCC cell lines and between HNSCC/ESCC and normal cells, which on average had lower OCR than HNSCC/ESCC cells. Both OCR and ECAR measurements were independently verified using the Seahorse technology. Additionally, using STO2p-Q, HNSCC/ESCC, and normal cells could be spatially resolved with a resolution in the low millimetre range. CONCLUSIONS: We developed a method to spatiotemporally measure OCR and ECAR of cells, which has many potential in vitro applications and lays the foundation for the development of novel diagnostic tools for the detection of cancerous tissue in HNSCC and ESCC patients in vivo.
BACKGROUND:pO2 and pH are physiological parameters relevant for different processes in health and disease, including wound healing and cancer progression. Head and neck squamous cell carcinomas (HNSCC) and oesophageal squamous cell carcinomas (ESCC) have a high rate of local recurrence that is partly related to treatment-resistant residual tumour cells. Hence, novel diagnostic tools are required to visualise potential residual tumour cells and thereby improve treatment outcome for HNSCC and ESCC patients. We developed a device to spatiotemporally measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) to distinguish HNSCC and ESCC cells from healthy cells in vitro, exploiting general metabolic differences between cancer cells and healthy cells. METHODS: OCR and ECAR were measured via a newly developed device named STO2p-Q (SpatioTemporal O2 and pH Quantification) using the VisiSens technology based on ratiometric fluorescence imaging, facilitating spatiotemporal resolution. Results were confirmed using extracellular flux analyses (Seahorse technology). RESULTS:STO2p-Q is described and used to measure OCR and ECAR in HNSCC and ESCC cell lines and normal fibroblast and epithelial cells as components of the tumour microenvironment. OCR measurements showed differences amongst HNSCC and ESCC cell lines and between HNSCC/ESCC and normal cells, which on average had lower OCR than HNSCC/ESCC cells. Both OCR and ECAR measurements were independently verified using the Seahorse technology. Additionally, using STO2p-Q, HNSCC/ESCC, and normal cells could be spatially resolved with a resolution in the low millimetre range. CONCLUSIONS: We developed a method to spatiotemporally measure OCR and ECAR of cells, which has many potential in vitro applications and lays the foundation for the development of novel diagnostic tools for the detection of cancerous tissue in HNSCC and ESCC patients in vivo.
Entities:
Keywords:
Cancer cell metabolism; ECAR; Head and neck squamous cell carcinoma; OCR; Oesophageal cell carcinomas; Ratiometric fluorescence imaging; Spatiotemporal pO2 and pH quantification (STO2p-Q); VisiSens technology
Authors: Bernhard G Weiss; Friedrich Ihler; Mahalia Zoe Anczykowski; Mattis Bertlich; Julia Kitz; Wolfgang Steiner; Martin Canis; Mark Jakob Journal: Head Neck Date: 2019-06-10 Impact factor: 3.147
Authors: Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona Journal: Nat Methods Date: 2012-06-28 Impact factor: 28.547
Authors: Stephan Schreml; Robert J Meier; Otto S Wolfbeis; Michael Landthaler; Rolf-Markus Szeimies; Philipp Babilas Journal: Proc Natl Acad Sci U S A Date: 2011-01-24 Impact factor: 11.205
Authors: J Gioanni; J L Fischel; J C Lambert; F Demard; C Mazeau; E Zanghellini; F Ettore; P Formento; P Chauvel; C M Lalanne Journal: Eur J Cancer Clin Oncol Date: 1988-09
Authors: Stephan Schreml; Robert J Meier; Michael Kirschbaum; Su Chii Kong; Sebastian Gehmert; Oliver Felthaus; Sarah Küchler; Justin R Sharpe; Kerstin Wöltje; Katharina T Weiß; Markus Albert; Uwe Seidl; Josef Schröder; Christian Morsczeck; Lukas Prantl; Claus Duschl; Stine F Pedersen; Martin Gosau; Mark Berneburg; Otto S Wolfbeis; Michael Landthaler; Philipp Babilas Journal: Theranostics Date: 2014-04-30 Impact factor: 11.556